← Back to Search

Community Support & Education for Opioid Use Disorder (CENS Trial)

N/A
Recruiting
Led By Alexander S Bennett, PhD
Research Sponsored by New York University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult (18+) age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 months follow-up assesment
Awards & highlights

CENS Trial Summary

This trial evaluates an intervention to reduce opioid-related risk behaviors in veterans with opioid use disorder. It involves peer outreach workers, educational sessions, healthcare navigation & social support. Findings will benefit community & civic healthcare orgs that provide overdose/HIV risk reduction.

Who is the study for?
This trial is for adult veterans with any severity of opioid use disorder who currently misuse opioids and are not connected to VA healthcare. Participants must be able to speak English and provide informed consent.Check my eligibility
What is being tested?
The study tests a peer-delivered, community-based education, navigation, and support intervention aimed at reducing opioid-related risks among veterans. It includes overdose education, safer substance use knowledge, treatment guidance, social service navigation, and peer support.See study design
What are the potential side effects?
Since the interventions involve educational sessions and social support rather than medical treatments or drugs, there are no direct side effects like those associated with medications.

CENS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

CENS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 months follow-up assesment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 months follow-up assesment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in HIV/HCV Risk Behaviors
Change in Opioid Overdose Risk Behaviors Scale
Secondary outcome measures
Drug Treatment
HIV/HCV Testing
Health service utilization

CENS Trial Design

2Treatment groups
Experimental Treatment
Group I: ControlExperimental Treatment1 Intervention
Participants will receive Overdose Education and Naloxone and referrals to treatment
Group II: CENS InterventionExperimental Treatment4 Interventions
Peer outreach workers will deliver Overdose Education and Naloxone to participants and provide education, navigation, and support during the 9-month intervention

Find a Location

Who is running the clinical trial?

New York UniversityLead Sponsor
226 Previous Clinical Trials
313,817 Total Patients Enrolled
Alexander S Bennett, PhDPrincipal InvestigatorNew York University

Media Library

Advanced Education in Safer Substance Use, Treatment, and Self-Care Clinical Trial Eligibility Overview. Trial Name: NCT05343169 — N/A
Opioid Use Disorder Research Study Groups: CENS Intervention, Control
Opioid Use Disorder Clinical Trial 2023: Advanced Education in Safer Substance Use, Treatment, and Self-Care Highlights & Side Effects. Trial Name: NCT05343169 — N/A
Advanced Education in Safer Substance Use, Treatment, and Self-Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT05343169 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the size of the participant pool for this research endeavor?

"Affirmative. According to the data on clinicaltrials.gov, this trial is presently recruiting patients and was first published on October 21st 2022. The most recent update took place June 29th 2023 and 300 participants need to be recruited from 1 location."

Answered by AI

Is the enrollment process for this trial still open?

"Affirmative. The information on clinicaltrials.gov shows that this medical research is actively searching for participants, which began to be recruited since October 21st 2022 and was last updated June 29th 2023. 300 patients will be incorporated in the study from a single location."

Answered by AI

Who else is applying?

What site did they apply to?
New York University
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0
~131 spots leftby Jun 2025